- NCIt
- C213011
Loading cancer entity…
Loading cancer entity…
Clinical trials
26 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07583810 | Non-covalent BTK Inhibitor Nemtabrutinib in Combination With the CD20 Monoclonal Antibody Rituximab for the Treatment of Marginal Zone Lymphoma | recruiting | Phase 2 | 35 | City of Hope Medical CenterOTHER | 1 | Sep 29, 2026 | clinicaltrials |
| NCT05098210 | Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer | recruiting | Phase 1 | 28 | Fred Hutchinson Cancer CenterOTHER | 1 | Jul 22, 2026 | clinicaltrials |
| NCT04704648 | Feasibility Study of Ocular Surface Squamous Neoplasia Surgical Excision in People Living With HIV in Sub-Saharan Africa | recruiting | N/A | 84 | AIDS Malignancy ConsortiumNETWORK | 1 | Mar 23, 2026 | clinicaltrials |
Data updated 20 hours agoSource updated Sep 29, 2026source: clinicaltrials
| Sentinel Lymph Node Biopsy in Ocular Surface and Adnexal Cancers(BLS) |
| recruiting |
| — |
| 25 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER |
| 1 |
| Oct 1, 2024 |
| clinicaltrials |